BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36248886)

  • 1. Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer.
    Liu X; Yan G; Xu B; Yu H; An Y; Sun M
    Front Immunol; 2022; 13():1006501. PubMed ID: 36248886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer.
    Chen IC; Lee KH; Hsu YH; Wang WR; Chen CM; Cheng YW
    Dis Markers; 2016; 2016():8169724. PubMed ID: 27578919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges.
    Peng X; Zhao Z; Liu L; Bai L; Tong R; Yang H; Zhong L
    Drug Des Devel Ther; 2022; 16():2639-2657. PubMed ID: 35965963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
    Sailer V; Sailer U; Bawden EG; Zarbl R; Wiek C; Vogt TJ; Dietrich J; Loick S; Grünwald I; Toma M; Golletz C; Gerstner A; Kristiansen G; Bootz F; Scheckenbach K; Landsberg J; Dietrich D
    EBioMedicine; 2019 Oct; 48():341-352. PubMed ID: 31628024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.
    Ma WJ; Wang X; Yan WT; Zhou ZG; Pan ZZ; Chen G; Zhang RX
    World J Gastroenterol; 2018 May; 24(20):2181-2190. PubMed ID: 29853736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.
    Huang Q; Xia J; Wang L; Wang X; Ma X; Deng Q; Lu Y; Kumar M; Zhou Z; Li L; Zeng Z; Young KH; Yi Q; Zhang M; Li Y
    J Hematol Oncol; 2018 Apr; 11(1):58. PubMed ID: 29685162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
    Kitsou M; Ayiomamitis GD; Zaravinos A
    Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell immune checkpoint landscape of PBMCs stimulated with
    Deng W; Su Z; Liang P; Ma Y; Liu Y; Zhang K; Zhang Y; Liang T; Shao J; Liu X; Han W; Li R
    Emerg Microbes Infect; 2021 Dec; 10(1):1272-1283. PubMed ID: 34120578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis.
    Mei J; Xie XX; Li MQ; Wei CY; Jin LP; Li DJ; Zhu XY
    Int J Clin Exp Pathol; 2014; 7(6):2743-57. PubMed ID: 25031694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
    Shi L; Mao H; Ma J
    BMC Med Genomics; 2024 May; 17(1):145. PubMed ID: 38802881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO1 in cancer: a Gemini of immune checkpoints.
    Zhai L; Ladomersky E; Lenzen A; Nguyen B; Patel R; Lauing KL; Wu M; Wainwright DA
    Cell Mol Immunol; 2018 May; 15(5):447-457. PubMed ID: 29375124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma.
    Struckmeier AK; Radermacher A; Fehrenz M; Bellin T; Alansary D; Wartenberg P; Boehm U; Wagner M; Scheller A; Hess J; Moratin J; Freudlsperger C; Hoffmann J; Thurner L; Roemer K; Freier K; Horn D
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3623-3635. PubMed ID: 35963900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma.
    Liang C; Peng L; Zeng S; Zhao Q; Tang L; Jiang X; Zhang J; Yan N; Chen Y
    Exp Eye Res; 2019 Apr; 181():112-119. PubMed ID: 30639792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
    Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.
    Shi D; Wu X; Jian Y; Wang J; Huang C; Mo S; Li Y; Li F; Zhang C; Zhang D; Zhang H; Huang H; Chen X; Wang YA; Lin C; Liu G; Song L; Liao W
    Nat Commun; 2022 Sep; 13(1):5644. PubMed ID: 36163134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the IDO1 pathway in cancer: from bench to bedside.
    Liu M; Wang X; Wang L; Ma X; Gong Z; Zhang S; Li Y
    J Hematol Oncol; 2018 Aug; 11(1):100. PubMed ID: 30068361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO1
    Pflügler S; Svinka J; Scharf I; Crncec I; Filipits M; Charoentong P; Tschurtschenthaler M; Kenner L; Awad M; Stift J; Schernthanner M; Bischl R; Herndler-Brandstetter D; Glitzner E; Moll HP; Casanova E; Timelthaler G; Sibilia M; Gnant M; Lax S; Thaler J; Müller M; Strobl B; Mohr T; Kaser A; Trajanoski Z; Heller G; Eferl R
    Commun Biol; 2020 May; 3(1):252. PubMed ID: 32444775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.